Vimarsana
Biggest News Aggregation in the World

Page 2 - Aaran Maree News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Aaran Maree. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Aaran Maree Today - Breaking & Trending Today

J&J vaccine blood clots, side effects detected in PA woman - Vimarsana News

J&J vaccine blood clots, side effects detected in PA woman

NorthJersey.com One of the six women who developed an extremely rare blood clotting disorder after receiving the Johnson & Johnson COVID-19 vaccine is a 26-year-old gym instructor from the New Jersey-Pennsylvania area, the pharmaceutical company told a federal advisory committee Wednesday.   Described as “overweight, but active,” the woman spent a week to 10 days in the hospital before being discharged with a prescription for anticoagulant medication, Dr. Aran Maree, the chief medical officer for the Janssen Pharmaceutical Companies of Johnson & Johnson, told the Advisory Committee...

What's ahead for the Johnson & Johnson vaccine? - Vimarsana News

What's ahead for the Johnson & Johnson vaccine?

The consensus: err on the side of caution and don’t rush anything. For now, the J&J vaccine remains on pause after seven women developed stroke-like symptoms after getting the shot. One of them died. “Confidence in this vaccine program and now the CDC is in grave, grave danger,” said Del Bigtree, CEO of the Informed Consent Action Network. As national health experts debated the fate of the J&J vaccine, they heard passionate pleas from the public. “We now have a vaccine that is just like the AstraZeneca vaccine in Europe – and I am honestly questioning the CDC,” Bigtree said.

CDC vaccine advisers put off decision on Johnson & Johnson Covid-19 vaccine - Vimarsana News

CDC vaccine advisers put off decision on Johnson & Johnson Covid-19 vaccine

CDC vaccine advisers put off decision on Johnson & Johnson Covid-19 vaccine Vaccine advisers to the US Centers for Disease Control and Prevention on Wednesday put off making any decision about the recommendations for Johnson & Johnson’s coronavirus vaccine, saying they need more information about a rare type of blood clot. Members of the Advisory Committee on Immunization Practices committee said they did not have enough information to make changes in their recommendations, or even to suggest extending a pause in administering the vaccine. The CDC and the US Food and Drug Administration rec...

PA Woman Hospitalized In NJ With Rare J&J Vaccine Related Blood Clot - Vimarsana News

PA Woman Hospitalized In NJ With Rare J&J Vaccine Related Blood Clot

Read / Add Comments One of the six women who developed clots as a result of the Johnson & Johnson COVID-19 vaccine is a Pennsylvania woman. The vaccine's use was temporarily halted nationwide after six women between the ages of 18 and 48 experienced blood clots. The New Jersey Health Department confirms that the woman they treated for the rare vaccine side effect is a resident of Pennsylvania who was hospitalized in New Jersey. The woman’s name will not be made public, but details about her have, she is 26, from an area bordering New Jersey and is gym instructor, according t...

Will the J&J vaccine 'pause' build trust in vaccine safety—or fuel vaccine hesitancy? - Vimarsana News

Will the J&J vaccine 'pause' build trust in vaccine safety—or fuel vaccine hesitancy?

Will the J&J vaccine 'pause' build trust in vaccine safety—or fuel vaccine hesitancy? The Advisory Committee on Immunization Practices (ACIP), a panel of outside experts that advises CDC on vaccines, on Wednesday declined to vote on whether use of Johnson & Johnson's (J&J) single-dose vaccine should resume—leaving the federal government's recommended pause in place until the committee's next meeting, which is expected within 10 days. ACIP declines to vote on whether to resume use of J&J's vaccine CDC and  FDA in a statement Thursday recommended a pause in the use of J&J's single-d...